GERON CORP
GERN · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Spiegel Robert J.: Form 4
Insider disclosure · Filed · Report period 30 Sep 2026
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- GERN · 374163103 - Common Stock, $0.001 par value per share
Company details and SEC sources
CIK 0000886744 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- GERN on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 919 East Hillsdale Boulevard, Suite 250, Foster City, CA, 94404
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- GERON CORPORATION (to 05 Aug 2005)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields